A Study on the Safety and Effectiveness of the Mantra™ Surgical Robotic System for Soft Tissue Surgeries
Launched by SUDHIR SRIVASTAVA INNOVATIONS PVT. LTD. · May 7, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the Mantra™ Surgical Robotic System, which is a new tool used during soft tissue surgeries to help doctors perform procedures more accurately and safely. The research aims to gather information about how well this robotic system works in real-life situations by looking back at previous surgeries that used this technology. The goal is to understand the system's safety and effectiveness, especially in helping patients recover from surgery with less risk.
To be eligible for this study, participants need to have had a surgery using the Mantra™ Surgical Robotic System. The study will focus on patients who have complete information about their surgeries; unfortunately, those with missing data won't be included. If you're considering participating or want to know more, this study is currently not recruiting, but it’s an important step in evaluating new surgical technologies to improve patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Participants must meet all of the following criteria to be eligible for inclusion in this retrospective clinical study of the SSI Mantra 3.0 Surgical Robotic System.
- • Patients who have previously undergone surgery using the Mantra™ Surgical Robotic System (Model 3.0) for the following procedures mentioned in Appendix D
- Exclusion Criteria:
- • Patients with missing data on primary endpoints.
About Sudhir Srivastava Innovations Pvt. Ltd.
Sudhir Srivastava Innovations Pvt. Ltd. is a forward-thinking clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient outcomes, the company specializes in the design, management, and execution of clinical trials across various therapeutic areas. Leveraging a robust network of healthcare professionals and cutting-edge technologies, Sudhir Srivastava Innovations aims to streamline the clinical development process while ensuring compliance with regulatory standards. Committed to ethical practices and patient safety, the organization strives to contribute significantly to the advancement of healthcare solutions globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangalore, Karnataka, India
Patients applied
Trial Officials
Prof. Dr. Somashekhar S P, MBBS, MS, MCh, FRCS, FRCS
Principal Investigator
Aster CMI Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported